8-K/A: Celcuity Inc. Appoints New Director, Expands Board

Celcuity Inc. announces the appointment of Charles (Chip) R. Romp to its Board of Directors, increasing the board size to eight members.

Summary

• Celcuity Inc. has amended its previous Form 8-K filing to provide updated details regarding a change in its Board of Directors.
• The company's Board size has been increased from seven to eight members.
• Charles (Chip) R. Romp has been appointed as a new director, effective immediately.
• Mr. Romp's term extends through the 2026 Annual Meeting of Stockholders.
• He has been deemed an independent director by Nasdaq and SEC standards.
• Effective May 14, 2026, Mr. Romp was appointed to the Compensation Committee and the Nominating and Corporate Governance Committee.
• Mr. Romp will receive compensation per the company's non-employee director program, including an annual cash retainer of $70,000 and an annual equity award valued at $135,000.
• Upon his appointment, Mr. Romp received a pro-rated grant of 215 shares of restricted stock, which vested on April 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative update regarding board composition and director appointments with standard compensation terms.

Positives

• Expansion of the Board of Directors with the addition of an independent director.
• Appointment of a new director, Charles (Chip) R. Romp, to fill a vacancy.
• Mr. Romp's immediate appointment to key committees (Compensation and Nominating/Corporate Governance).
• Clear compensation structure for the new director, including cash retainer and equity awards.
• Grant of restricted stock to the new director, aligning his interests with shareholders.

Negatives

• The filing is an amendment to a previous report, indicating a need for correction or supplementation of information.
• The expansion of the board may lead to increased director compensation costs.

Risks

• No specific risks were detailed in this amendment regarding the director appointment.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the terms of the new director's appointment and committee service.

Management Comments

• The Board of Directors, upon the recommendation of the Nominating and Corporate Governance Committee, voted to increase the size of the Board from seven members to eight members and to appoint Charles (Chip) R. Romp as a new director to fill the resulting vacancy.
• The Board determined that Mr. Romp qualifies as an independent director pursuant to the listing standards of The Nasdaq Stock Market LLC and the rules of the U.S. Securities and Exchange Commission.

Industry Context

StockSavvy.ai notes that board expansion and the appointment of independent directors are common governance practices, especially for companies listed on major exchanges like Nasdaq, aiming to enhance oversight and strategic guidance.

Comparison to Industry Standards

• The compensation structure for Mr. Romp, including a cash retainer and equity awards, aligns with typical compensation packages for independent directors at publicly traded biotechnology companies of similar size and stage.
• The requirement for directors to meet Nasdaq and SEC independence standards is a baseline expectation for listed companies.

Management Changes

Corporate Governance

Related Party Transactions

• There are no disclosed relationships or related transactions between Mr. Romp and the Company that require reporting under Item 404(a) of Regulation S-K.

Stakeholder Impact

• Shareholders: The addition of an independent director and expansion of the board may be viewed positively for governance, but increased director compensation could be a minor concern.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Mr. Romp will serve on the Board of Directors through the 2026 Annual Meeting of Stockholders.
• Mr. Romp will serve on the Compensation Committee and the Nominating and Corporate Governance Committee.

Key Dates

Keywords

Celcuity Inc., Board of Directors, Director Appointment, Corporate Governance, Charles Romp, Compensation Committee, Nominating Committee, Form 8-K/A